Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Syndax Pharmaceuticals
SNDX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$18.18
-0.09
-0.49%
Pre-Market: Sep 20, 7:01 PM EDT
15 minutes delayed
Get Report
Comment
Syndax Pharmaceuticals (SNDX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock
Syndax Pharmaceuticals Stock (NASDAQ: SNDX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, September 18, 2024
Incyte, Syndax Report Publication Of Data Fro...
Benzinga Newsdesk
Wednesday, September 04, 2024
Syndax Pharmaceuticals Partnered With Foundat...
Benzinga Newsdesk
Friday, August 16, 2024
Citigroup Maintains Buy on Syndax Pharmaceuti...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Maintains Buy on Syndax P...
Benzinga Newsdesk
B of A Securities Maintains Buy on Syndax Pha...
Benzinga Newsdesk
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
Vandana Singh
Barclays Maintains Overweight on Syndax Pharm...
Benzinga Newsdesk
Wednesday, August 14, 2024
Incyte, Syndax Secure FDA Approval For Niktim...
Benzinga Newsdesk
Monday, August 12, 2024
Syndax Pharmaceuticals Announced That Data Fr...
Benzinga Newsdesk
Tuesday, August 06, 2024
JP Morgan Maintains Overweight on Syndax Phar...
Benzinga Newsdesk
Friday, August 02, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Thursday, August 01, 2024
Syndax Pharmaceuticals Q2 2024 GAAP EPS $(0.8...
Benzinga Newsdesk
Monday, July 29, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Syndax Pharmaceuticals shares are trading low...
Benzinga Newsdesk
FDA Extends Review Period for Syndax Pharmace...
Benzinga Newsdesk
Friday, June 28, 2024
Jefferies Initiates Coverage On Syndax Pharma...
Benzinga Newsdesk
Wednesday, June 26, 2024
Stifel Maintains Buy on Syndax Pharmaceutical...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Friday, June 14, 2024
Syndax Pharmaceuticals Discloses Updated Data...
Benzinga Newsdesk
Thursday, June 06, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Syndax's Revumenib To Enter Phase 1b For Meta...
Benzinga Newsdesk
Wednesday, May 29, 2024
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, May 21, 2024
JP Morgan Maintains Overweight on Syndax Phar...
Benzinga Newsdesk
Thursday, May 09, 2024
Citigroup Maintains Buy on Syndax Pharmaceuti...
Benzinga Newsdesk
Stifel Maintains Buy on Syndax Pharmaceutical...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Syndax Pharmaceuticals Q1 2024 GAAP EPS $(0.8...
Benzinga Newsdesk
Friday, April 26, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Monday, April 08, 2024
Syndax Pharmaceuticals Announced The Presenta...
Benzinga Newsdesk
Wednesday, April 03, 2024
Live On CNBC, StemPoint Capital CIO Michelle ...
Benzinga Newsdesk
Thursday, March 28, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Syndax Disclosed Completion Of Enrollment In ...
Benzinga Newsdesk
Wednesday, March 27, 2024
HC Wainwright & Co. Maintains Buy on Syndax P...
Benzinga Newsdesk
Tuesday, March 26, 2024
Syndax Reports FDA Priority Review Of NDA For...
Benzinga Newsdesk
Wednesday, March 20, 2024
JP Morgan Maintains Overweight on Syndax Phar...
Benzinga Newsdesk
Wednesday, February 28, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Tuesday, February 27, 2024
Syndax Pharmaceuticals Expects $600M In Cash ...
Benzinga Newsdesk
Syndax Pharmaceuticals: Q4 Earnings Insights
Benzinga Insights
Syndax Pharmaceuticals Q4 2023 GAAP EPS $(1.0...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
Earnings Preview: Syndax Pharmaceuticals
Benzinga Insights
Wednesday, January 31, 2024
Scotiabank Downgrades Syndax Pharmaceuticals ...
Benzinga Newsdesk
Tuesday, January 02, 2024
HC Wainwright & Co. Reiterates Buy on Syndax ...
Benzinga Newsdesk
Syndax Highlights Recent Updates And Anticipa...
Benzinga Newsdesk
Friday, December 22, 2023
HC Wainwright & Co. Maintains Buy on Syndax P...
Benzinga Newsdesk
Mizuho Initiates Coverage On Syndax Pharmaceu...
Benzinga Newsdesk
Friday, December 15, 2023
Syndax Prices $200M Public Offering of 10,810...
Benzinga Newsdesk
Thursday, December 14, 2023
Syndax Announces Proposed $150M Public Offeri...
Benzinga Newsdesk
Tuesday, December 12, 2023
Syndax Presents Data From Pivotal AUGMENT-101...
Benzinga Newsdesk
Monday, December 11, 2023
What's Going On With Leukemia-Focused Syndax Pharmaceuticals Stock Today?
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch